到 2030 年临床试验患者招募服务的市场预测：按治疗领域、阶段、年龄组和地区进行的全球分析

根据 Stratistics MRC 的数据，2023 年全球临床试验患者招募服务市场规模为 11.9 亿美元，预计在预测期内年复合成长率为 11.5%，到 2030 年将达到 25.5 亿美元。

专门帮助研究人员和製药公司寻找和招募合格的临床试验患者进行临床试验的服务称为临床试验患者招募服务。为了更快开始临床试验，病患招募服务可以加快识别和招募合格参与者的过程。为了让研究人员更了解治疗方法在不同人群中的有效性和安全性，拥有更多样化和代表性的患者群体至关重要，而这可以透过患者招募服务来保证，这是一个要素。

根据 ClinicalTrial.gov 统计，过去年度临床试验增加了 49.2%。

临床试验数量增加

推动临床试验患者招募服务市场的主要因素之一是临床试验数量的增加。药物研究、医学研究以及对新疗法和治疗方法的探索的持续发展是临床试验活动增加的主要驱动力。随着製药和生物技术公司、学术机构和研究机构配合措施将新药、医疗设备和治疗方法推向市场，对专业患者招募服务的需求不断增加。

预算限制

预算限制是研究机构和製药公司的典型问题。病患招募服务对于临床实验的顺利进行至关重要，但其成本是一个主要因素。这些服务通常涉及大量成本，包括僱用员工、使用最尖端科技、广告和推广计划来寻找和联繫潜在的临床试验参与者。此外，患者招募服务提供者可能会感到在竞争激烈的市场中提供竞争的价格的压力，这可能会影响报酬率以及投资尖端策略和技术的能力。因此，这是市场成长的主要障碍。

先进的技术

许多招聘机构正在利用人工智慧和资料分析等先进技术来提高参与者识别的准确性和效率。患者招募服务越来越多地使用资料分析，透过筛选大型资料来快速且准确地识别潜在的临床试验参与者。这种分析方法可以透过系统地评估各种患者特征和病历来确定符合每个临床试验确切要求的人。这些因素正在推动市场需求。

法规挑战

临床试验的法规环境复杂且不断变化。招聘机构可能会发现很难遵守不断变化的法规，例如资料保护和知情同意法规。此外，对于适用于临床试验的病患隐私、资料保护和知情同意也有严格的法规。患者招募服务可能难以遵守法规机构关于患者资料收集、储存和共用的严格准则。这些因素都阻碍了市场的扩张。

COVID-19 的影响

COVID-19 大流行对临床试验患者招募服务市场产生了重大影响。许多正在进行的临床试验因疫情而中断，这对临床试验入组和患者招募产生了重大负面影响。逐步淘汰、旅行禁令和使用医疗设施的限制使得临床实验难以按计划进行。患者招募服务与高科技公司合作，提高远端监控能力并收集即时患者资料，同时最大限度地减少亲自就诊的需要。

预计预测期内呼吸系统疾病领域规模最大

预计呼吸系统疾病领域将占最大份额。临床试验招募服务呼吸疾病部门专注于临床研究的特定领域，致力于开发各种呼吸系统疾病的治疗方法。临床试验对于评估新药、吸入器、生物製药和医疗设备增强肺功能、减轻症状和预防病情恶化的安全性和有效性至关重要。

预计第二期细分市场在预测期间内年复合成长率最高

预计二期业务在预测期内将出现良好成长。在临床研究中，II期临床试验是I期试验之后、III期试验前发生的重要阶段。 II 期临床试验的主要目的是评估新治疗方法和药物在较大患者群体中的安全性和有效性。 II 期临床试验病患招募服务负责识别和招募符合临床实验试验方案中具体要求的合格参与者。

占比最高的地区

由于北美正在进行大量活跃的临床试验，因此在估计期间占据最大的市场占有率，预计市场将快速扩张。该产业也受到大量研发支出和政府对临床试验的资助的推动。北美的行业成长是由顶级委外研发机构(CRO) 的存在推动的，这些组织提供患者招募等广泛的支援服务，以及全球製药和生物製药公司的积极参与。

复合年复合成长率最高的地区：

预计亚太地区在预测期内将实现盈利成长。临床试验向印度、日本和韩国等新兴国家的离岸外包正在增加。这是因为患者群庞大且临床试验成本低廉，进一步促进了区域扩张。合格的医疗人员、强大的医院网路以及研发基础设施的发展都有助于亚太市场的扩张。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

• 公司简介
  • 其他市场参与企业的综合分析（最多 3 家公司）
  • 主要企业SWOT分析（最多3家企业）
• 区域分割
  • 根据客户兴趣对主要国家的市场估计/预测/年复合成长率（註：基于可行性检查）
• 竞争基准化分析
  • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

• 概述
• 利害关係人
• 调查范围
• 调查方法
  • 资料探勘
  • 资料分析
  • 资料检验
  • 研究途径
• 调查来源
  • 主要调查来源
  • 二次调查来源
  • 先决条件

第3章市场趋势分析

• 介绍
• 促进因素
• 抑制因素
• 机会
• 威胁
• 新兴市场
• 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

• 供应商的议价能力
• 买方议价能力
• 替代品的威胁
• 新进入者的威胁
• 竞争公司之间的敌对关係

第5章全球临床试验病患招募服务市场：依治疗领域

• 介绍
• 中枢神经系统
• 抗感染疾病
• 内分泌
• 呼吸系统疾病
• 心血管
• 疼痛和麻醉
• 肿瘤学
• 皮肤病
• 血液疾病
• 其他治疗领域

第6章全球临床试验病患招募服务市场：依阶段

• 介绍
• 第一阶段
• 第二阶段
• 第三阶段
• 第四阶段

第7章全球临床试验病患招募服务市场：依年龄组

• 介绍
• 婴儿
• 成人

第8章全球临床试验病患招募服务市场：按地区

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 纽西兰
  • 韩国
  • 其他亚太地区
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 卡达
  • 南非
  • 中东和非洲其他地区

第9章进展

• 合约、伙伴关係、协作和合资企业
• 收购和合併
• 新产品发布
• 业务扩展
• 其他关键策略

第10章公司简介

• Clinical Site Services
• Clara Health
• Worldwide Clinical Trials
• Clariness
• Veristat
• PPD Inc
• BBK Worldwide
• Elligo Health Research
• Antidote Technologies, Inc.
• IQVIA
• Matthews Media Group Inc.
• Conduent, Inc.
• Biorasi, LLC
• Trialfacts
• Syneos Health

According to Stratistics MRC, the Global Clinical Trial Patient Recruitment Services Market is accounted for $1.19 billion in 2023 and is expected to reach $2.55 billion by 2030 growing at a CAGR of 11.5% during the forecast period. Services specifically designed to assist researchers and pharmaceutical companies in finding and recruiting qualified subjects for their clinical trials are known as clinical trial patient recruitment services. In order to help clinical trials get underway more quickly, patient recruitment services can speed up the process of identifying and enrolling eligible participants. For researchers to better understand a treatment's efficacy and safety across a range of demographic groups it is imperative to have a more diverse and representative patient population, which is a factor that patient recruitment services can help ensure.

According to ClinicalTrial.gov, there has been a 49.2% rise in clinical trials over the past 5 years.

Market Dynamics:

Driver:

Rising Number of Clinical Trials

One major factor propelling the market for clinical trial patient recruitment services is the rise in the number of clinical trials. The ongoing developments in pharmaceutical research, medical research, and the search for novel therapies and treatments are the main drivers of this rise in clinical trial activity. Specialized patient recruitment services are in increasing demand as pharmaceutical and biotechnology companies, academic institutions, and research organizations step up their efforts to introduce novel drugs, medical devices, and therapies to the market.

Restraint:

Budgetary restrictions

Budgetary restrictions are a typical problem for research institutions and pharmaceutical companies. Although patient recruitment services are essential to the smooth running of trials, their costs can be a significant factor. These services usually come with a number of costs, such as hiring staff, using cutting-edge technologies, advertising, and outreach programs to find and connect possible trial participants. Furthermore, providers of patient recruitment services may feel pressured to offer competitive pricing in a market that is fiercely competitive, which could affect their profit margins and capacity to make investments in cutting-edge tactics and technologies. Therefore, it is a significant barrier to market growth.

Opportunity:

Advanced technologies

Numerous recruitment agencies use advanced technologies, like artificial intelligence and data analytics, to improve participant identification accuracy and efficiency. Data analytics is being used by patient recruitment services in increasing numbers to quickly and accurately identify possible trial participants by sorting through large datasets. This analytical method makes it possible to identify people who fit the precise requirements of each clinical trial by methodically evaluating a variety of patient characteristics and medical histories. These factors propel market demand.

Threat:

Regulatory challenges

The regulatory landscape for clinical trials is complex and subject to constant change. Recruitment agencies may find it difficult to remain compliant with changing regulations, such as those pertaining to data protection and informed consent. Additionally, there are stringent regulations pertaining to patient privacy, data protection, and informed consent that apply to clinical trials. Patient recruitment services may find it difficult to comply with regulatory bodies' strict guidelines when it comes to gathering, storing, and sharing patient data. These factors hamper market expansion.

COVID-19 Impact

The COVID-19 pandemic has had a significant impact on the clinical trial patient recruitment services market. Numerous ongoing clinical trials were disrupted by the pandemic, which had a significant negative impact on trial enrolment and patient recruitment. Phase-outs, travel bans, and restricted access to medical facilities made it difficult to carry out trials as scheduled. In order to improve remote monitoring capabilities and collect real-time patient data while minimizing the need for in-person visits, patient recruitment services worked with tech companies.

The respiratory diseases segment is expected to be the largest during the forecast period

The respiratory diseases segment is estimated to hold the largest share. The Clinical Trial Patient Recruitment Services' respiratory diseases section focuses on a particular field of clinical research that is committed to the creation of cures and treatments for a range of respiratory ailments. For the purpose of assessing the safety and effectiveness of novel medications, inhalers, biologics, and medical devices intended to enhance lung function, reduce symptoms, or stop exacerbations, clinical trials are crucial.

The phase II segment is expected to have the highest CAGR during the forecast period

The phase II segment is anticipated to have lucrative growth during the forecast period. In the clinical research spectrum, Phase II clinical trials are a crucial stage that comes after Phase I trials and before Phase III trials. The main goals of Phase II trials are to evaluate a new treatment or medication's safety and effectiveness in a larger patient population. The Phase II segment recruitment services are responsible for identifying and enrolling eligible participants who meet the precise requirements specified in the trial protocol.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the large number of active clinical trials in the region, the market is anticipated to increase rapidly. Significant R&D expenditures and government funding for clinical studies also drive the industry. The industry's growth in North America has been facilitated by the existence of top contract research organizations (CROs) that provide extensive support services, such as patient recruiting, and by the active involvement of global pharmaceutical and biopharmaceutical corporations.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. There is an increase in off shoring clinical trials to emerging economies like India, Japan, South Korea, and others. This is because there is a large patient pool and trials are inexpensive, which further promotes regional expansion. The availability of qualified medical professionals, a robust hospital network, and developed clinical research infrastructure are all contributing to the Asia-Pacific market's expansion.

Key players in the market

Some of the key players in the Clinical Trial Patient Recruitment Services Market include: Clinical Site Services, Clara Health, Worldwide Clinical Trials, Clariness, Veristat, PPD Inc, BBK Worldwide, Elligo Health Research, Antidote Technologies, Inc., IQVIA, Matthews Media Group Inc., Conduent, Inc., Biorasi, LLC, Trialfacts and Syneos Health.

Key Developments:

In August 2023, Worldwide Clinical partners with Cybin for psychedelic-based treatments. Cybin, a biopharma developing psychedelic-based treatment options for mental health issues.

In December 2021, worldwide clinical Trials and WCG partner to accelerate and streamline global safety event distribution. Worldwide offers a comprehensive suite of pharmacovigilance capabilities, including a regulatory intelligence database that is unique to the company and enhanced by WCG's proprietary Safety Vigilance portal.

Therapeutic Areas Covered:

• Central Nervous System
• Anti-Infective
• Endocrine
• Respiratory Diseases
• Cardiovascular
• Pain & Anaesthesia
• Oncology
• Dermatological Disorders
• Haematological Disorders
• Other Therapeutic Areas

Phases Covered:

• Phase I
• Phase II
• Phase Ill
• Phase IV

Age Groups Covered:

• Child
• Adult

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Emerging Markets
• 3.7 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Clinical Trial Patient Recruitment Services Market, By Therapeutic Areas

• 5.1 Introduction
• 5.2 Central Nervous System
• 5.3 Anti-Infective
• 5.4 Endocrine
• 5.5 Respiratory Diseases
• 5.6 Cardiovascular
• 5.7 Pain & Anesthesia
• 5.8 Oncology
• 5.9 Dermatological Disorders
• 5.10 Hematological Disorders
• 5.11 Other Therapeutic Areas

6 Global Clinical Trial Patient Recruitment Services Market, By Phase

• 6.1 Introduction
• 6.2 Phase I
• 6.3 Phase II
• 6.4 Phase Ill
• 6.5 Phase IV

7 Global Clinical Trial Patient Recruitment Services Market, By Age Group

• 7.1 Introduction
• 7.2 Child
• 7.3 Adult

8 Global Clinical Trial Patient Recruitment Services Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Clinical Site Services
• 10.2 Clara Health
• 10.3 Worldwide Clinical Trials
• 10.4 Clariness
• 10.5 Veristat
• 10.6 PPD Inc
• 10.7 BBK Worldwide
• 10.8 Elligo Health Research
• 10.9 Antidote Technologies, Inc.
• 10.10 IQVIA
• 10.11 Matthews Media Group Inc.
• 10.12 Conduent, Inc.
• 10.13 Biorasi, LLC
• 10.14 Trialfacts
• 10.15 Syneos Health

List of Tables

• Table 1 Global Clinical Trial Patient Recruitment Services Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
• Table 3 Global Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 4 Global Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
• Table 5 Global Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
• Table 6 Global Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
• Table 7 Global Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 8 Global Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
• Table 9 Global Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
• Table 10 Global Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
• Table 11 Global Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
• Table 12 Global Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
• Table 13 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
• Table 14 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
• Table 15 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
• Table 16 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
• Table 17 Global Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
• Table 18 Global Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
• Table 19 Global Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
• Table 20 Global Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
• Table 21 North America Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
• Table 22 North America Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
• Table 23 North America Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 24 North America Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
• Table 25 North America Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
• Table 26 North America Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
• Table 27 North America Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 28 North America Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
• Table 29 North America Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
• Table 30 North America Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
• Table 31 North America Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
• Table 32 North America Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
• Table 33 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
• Table 34 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
• Table 35 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
• Table 36 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
• Table 37 North America Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
• Table 38 North America Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
• Table 39 North America Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
• Table 40 North America Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
• Table 41 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
• Table 42 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
• Table 43 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 44 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
• Table 45 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
• Table 46 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
• Table 47 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 48 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
• Table 49 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
• Table 50 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
• Table 51 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
• Table 52 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
• Table 53 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
• Table 54 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
• Table 55 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
• Table 56 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
• Table 57 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
• Table 58 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
• Table 59 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
• Table 60 Europe Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
• Table 61 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
• Table 62 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
• Table 63 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 64 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
• Table 65 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
• Table 66 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
• Table 67 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 68 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
• Table 69 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
• Table 70 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
• Table 71 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
• Table 72 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
• Table 73 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
• Table 74 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
• Table 75 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
• Table 76 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
• Table 77 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
• Table 78 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
• Table 79 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
• Table 80 Asia Pacific Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
• Table 81 South America Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
• Table 82 South America Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
• Table 83 South America Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 84 South America Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
• Table 85 South America Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
• Table 86 South America Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
• Table 87 South America Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 88 South America Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
• Table 89 South America Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
• Table 90 South America Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
• Table 91 South America Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
• Table 92 South America Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
• Table 93 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
• Table 94 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
• Table 95 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
• Table 96 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
• Table 97 South America Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
• Table 98 South America Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
• Table 99 South America Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
• Table 100 South America Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)
• Table 101 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Country (2021-2030) ($MN)
• Table 102 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Therapeutic Areas (2021-2030) ($MN)
• Table 103 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Central Nervous System (2021-2030) ($MN)
• Table 104 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Anti-Infective (2021-2030) ($MN)
• Table 105 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Endocrine (2021-2030) ($MN)
• Table 106 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
• Table 107 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Cardiovascular (2021-2030) ($MN)
• Table 108 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Pain & Anesthesia (2021-2030) ($MN)
• Table 109 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Oncology (2021-2030) ($MN)
• Table 110 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Dermatological Disorders (2021-2030) ($MN)
• Table 111 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Hematological Disorders (2021-2030) ($MN)
• Table 112 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
• Table 113 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase (2021-2030) ($MN)
• Table 114 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase I (2021-2030) ($MN)
• Table 115 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase II (2021-2030) ($MN)
• Table 116 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase Ill (2021-2030) ($MN)
• Table 117 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Phase IV (2021-2030) ($MN)
• Table 118 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Age Group (2021-2030) ($MN)
• Table 119 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Child (2021-2030) ($MN)
• Table 120 Middle East & Africa Clinical Trial Patient Recruitment Services Market Outlook, By Adult (2021-2030) ($MN)